Trial Profile
A Randomized Comparison of Two Dosage Schedules of Intravitreal ISIS 2922 for Patients With Advanced Cytomegalovirus Retinitis
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Fomivirsen (Primary)
- Indications Cytomegalovirus retinitis
- Focus Therapeutic Use
- Sponsors Ionis Pharmaceuticals
- 08 Jan 2016 New trial record